Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma

被引:140
作者
Jarnagin, WR
Bowne, W
Klimstra, DS
Ben-Porat, L
Roggin, K
Cymes, K
Fong, YM
DeMatteo, RP
D'Angelica, M
Koea, J
Blumgart, LH
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
关键词
D O I
10.1097/01.sla.0000160817.94472.fd
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The Current study compares outcome after resection of papillary hilar cholangiocarcinoma to that of the more common nodular-sclerosing subtype. Methods: Clinical, radiologic, histopathologic, and survival data on all patients with hilar cholangiocarcinoma were analyzed. Resected tumors were reexamined and classified as nodular-sclerosing (no component of papillary carcinoma) or papillary (any component of papillary carcinoma): for papillary tumors, the proportion of invasive carcinoma present was determined. Differences in the clinical behavior and histopathologic features of nodular-sclerosing and papillary tumors were assessed. Results: From January 1991 to November 2003, 279 patients were evaluated, 154 men (55.2%) and 125 women (44.8%), with a mean age of 65.4 +/- 0.7 years (median = 68, range 23-87 years). Of the 215 patients explored, 106 (49.5%) underwent a complete gross resection. An en bloc partial hepatectomy (n = 87) and an R0 resection (n = 82) were independent predictors of favorable outcome. Operative mortality was 7.5% but was 2.8% over the last 4 years of the Study, and there were no operative deaths in the last 33 consecutive resections. Twenty-five resected tumors (23.6%) contained a papillary component: 12 were minimally or noninvasive (< 10% invasive cancer) and 13 had an invasive component ranging from 10% to 95% (>= 10%). Patients with papillary and nodular-sclerosing tumors had similar demographics, operative procedures, and proportion of R0 resections. By contrast, papillary tumors were significantly larger. more often well-differentiated, and earlier stage. Disease-specific survival after resection of papillary tumors (55.7 months) was greater than after resection of nodular-sclerosing lesions (33.5 months, P = 0.013). The papillary phenotype was an independent predictor of survival, although the benefit was more pronounced for less invasive tumors. Conclusions: The presence of a component of papillary carcinoma is more common than previous reports have Suggested and is an important determinant of survival after resection of hilar cholangiocarcinoma.
引用
收藏
页码:703 / 714
页数:12
相关论文
共 34 条
[1]   Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract [J].
Abraham, SC ;
Lee, JH ;
Hruban, RH ;
Argani, P ;
Furth, EE ;
Wu, TT .
HUMAN PATHOLOGY, 2003, 34 (09) :902-910
[2]  
Albores-Saavedra J, 2000, CANCER, V89, P508, DOI 10.1002/1097-0142(20000801)89:3<508::AID-CNCR5>3.0.CO
[3]  
2-D
[4]  
[Anonymous], 2002, AJCC CANC STAG MAN
[5]  
BELGHITI J, 1994, EUR J SURG, V160, P277
[6]  
BLUMGART LH, 1989, SURG CLIN N AM, V69, P323
[7]  
Burke EC, 1998, ANN SURG, V228, P385, DOI 10.1097/00000658-199809000-00011
[8]  
COX DR, 1972, J R STAT SOC B, V34, P187
[9]   Hepatectomy with portal vein resection for hilar cholangiocarcinoma - Audit of 52 consecutive cases [J].
Ebata, T ;
Nagino, M ;
Kamiya, J ;
Uesaka, K ;
Nagasaka, T ;
Nimura, Y .
ANNALS OF SURGERY, 2003, 238 (05) :720-727
[10]   T cell development: Some cells get all the breaks [J].
Green, DR ;
Schuler, M .
NATURE IMMUNOLOGY, 2000, 1 (01) :15-17